WebTreatment consisted of 5-Fluorouracil (5-FU) on cis-platinum (CDDP). 5-FU was given at 1000 mg/m2 per day as continuous infusions during 4 days, and 60 mg/m2 of CDDP was given on day 4 beginning on day 1 and 35 of a concurrent chemoradiotherapy course. ... Radiation was given in single daily fractions of 2 Gy and 5 fractions per week to a total ... WebObjective To identify any additional benefit and note the safety profile of neoadjuvant chemotherapy prior to concurrent chemoradiation in muscle-invasive bladder cancer. Methods Forty three patients with T2b-T4N0M0 bladder cancer underwent maximal TURBT followed by neoadjuvant chemotherapy cisplatinum 75 mg/m[2] D1+ gemcitabine 1000 …
Cisplatin Every 3 Weeks Versus Weekly With Definitive ... - PubMed
WebA multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high … WebFeb 20, 2024 · Cisplatin 35mg/m ² IV concurrently weekly for 6 doses with radiation. Pembrolizumab commences concurrently with radiation and is given 200mg IV q21 days for 7 doses. Surveillance... lccc binformation
Efficacy and tolerability of concurrent weekly low dose …
WebUHN WebMethods: Seventeen patients with esophageal cancer were enrolled between July 2014 and December 2015.The treatment included radical radiotherapy (95% planning target volume 60Gy/30f) and concurrent chemotherapy comprising nab-paclitaxel 60mg/m2/week plus cisplatin 25mg/m2/week, administered on days 1, 8, 15, and 22 of each 28-day cycle. WebApr 24, 2024 · Patients receive at least 3 of 4 weekly cycles of cisplatin (35mg/m2) Treatment length up to 35 days. Grade 4 toxicity lower than 25% Study Type Interventional Enrollment (Actual) 20 Phase Not Applicable Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. lccc bursar\u0027s office